<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">surgonco</journal-id><journal-title-group><journal-title xml:lang="ru">Креативная хирургия и онкология</journal-title><trans-title-group xml:lang="en"><trans-title>Creative surgery and oncology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2076-3093</issn><issn pub-type="epub">2307-0501</issn><publisher><publisher-name>Башкирский государственный медицинский университет</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24060/2076-3093-2022-12-4-275-281</article-id><article-id custom-type="elpub" pub-id-type="custom">surgonco-731</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Рациональность биопсии сигнальных лимфатических узлов в диагностике и малоинвазивном лечении пациентов с раком молочной железы</article-title><trans-title-group xml:lang="en"><trans-title>Rationality of sentinel node biopsy in the diagnosis and minimally invasive treatment of patients with breast cancer</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1971-5092</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Букин</surname><given-names>Э. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Bukin</surname><given-names>E. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Букин Эдуард Максимович — отделение опухолей молочной железы и кожи</p><p>Ярославль</p></bio><bio xml:lang="en"><p>Eduard M. Bukin — Unit of Breast and Skin Tumors</p><p>Yaroslavl</p></bio><email xlink:type="simple">eduardbukin1991@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0066-4969</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Васин</surname><given-names>А. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Vasin</surname><given-names>A. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Васин Александр Борисович</p><p>Ярославль</p></bio><bio xml:lang="en"><p>Alexander B. Vasin</p><p>Yaroslavl</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8467-0591</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Голощапова</surname><given-names>Н. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Goloshchapova</surname><given-names>N. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Голощапова Наталья Сергеевна — дневной стационар</p><p>Ярославль</p></bio><bio xml:lang="en"><p>Natalya S. Goloshchapova — Day Hospital</p><p>Yaroslavl</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Областная клиническая онкологическая больница</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Regional Clinical Oncological Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>02</day><month>01</month><year>2023</year></pub-date><volume>12</volume><issue>4</issue><fpage>275</fpage><lpage>281</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Букин Э.М., Васин А.Б., Голощапова Н.С., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Букин Э.М., Васин А.Б., Голощапова Н.С.</copyright-holder><copyright-holder xml:lang="en">Bukin E.M., Vasin A.B., Goloshchapova N.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.surgonco.ru/jour/article/view/731">https://www.surgonco.ru/jour/article/view/731</self-uri><abstract><sec><title>Введение</title><p>Введение. Биопсия сигнального лимфатического узла является «золотым стандартом» в диагностике поражения лимфатических коллекторов при раке молочной железы. Несмотря на долгую историю метода, до сих пор остаются нерешенными некоторые практические вопросы, связанные с ее экономическими и социальными преимуществами и недостатками.</p></sec><sec><title>Цели</title><p>Цели: на основании опыта применения биопсии сигнального лимфатического узла в условиях Ярославской областной онкологической больницы рассмотреть рациональность подходов в диагностике и малоинвазивном лечении пациентов с раком молочной железы.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Проведен анализ 942 историй болезни пациентов с раком молочной железы, прошедших хирургический этап лечения в Ярославской областной онкологической больнице. По результатам исследования у 16 % процентов пациентов с первой и второй клиническими стадиями имелось изменение изначального статуса лимфоколлекторов после патолого-анатомического исследования удаленных лимфатических узлов. Это послужило основанием для изменения тактики предоперационного обследования пациентов и назначения магнитно-резонансной томографии молочных желез и зон регионарного оттока лимфы 64 пациентам перед планированием биопсии сигнального лимфатического узла. Результаты и обсуждение. Данные магнитно-резонансной томографии коррелировали с результатами, полученными после гистологического исследования, и позволяли рационально определить объем хирургического пособия, снижающего риски повторного вмешательства и возможного локорегионарного рецидива.</p></sec><sec><title>Заключение</title><p>Заключение. Биопсия сигнального лимфатического узла — метод, сочетающий в себе высокую информативность, безопасность и экономическую выгоду. Однако комплексный подход к предоперационному обследованию и принцип коллегиальности в выборе лечебной тактики должны соблюдаться во всех случаях для достижения большей пациентоориентированности.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Sentinel node biopsy is the gold standard in the diagnosis of lymph node basin lesions in breast cancer. Although the method has got a long history of its application, some practical issues related to its economic and social advantages and disadvantages remain unresolved.</p></sec><sec><title>Aims</title><p>Aims. To consider the efficiency of approaches to the diagnosis and minimally invasive treatment in breast cancer, following the experience of sentinel node biopsy in Regional Clinical Oncological Hospital, Yaroslavl.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. Th e present paper involves the analysis of 942 histories of breast cancer patients who have undergone surgical treatment at Regional Clinical Oncological Hospital, Yaroslavl. According to the study results, 16% of stage I and II patients had a change in the initial status of lymph node basins aft er pathoanatomical examination of the removed lymph nodes. Th is prompted a change in preoperative examination and appointment of MRI of breast and lymph regional outflow for 64 patients prior to planning a sentinel lymph node biopsy.</p></sec><sec><title>Results and discussion</title><p>Results and discussion. Magnetic resonance imaging data correlated with the results obtained aft er histological examination and served to determine the extent of surgical treatment, reducing the risks of reintervention and locoregional recurrence.</p></sec><sec><title>Conclusion</title><p>Conclusion. Sentinel node biopsy is a method that combines high informativity, safety and economic benefits. However, in order to achieve greater patient focus, a comprehensive approach to preoperative examination and principle of cooperation in the choice of treatment strategy should be observed in all cases.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>рак молочной железы</kwd><kwd>сигнальный лимфатический узел</kwd><kwd>биопсия</kwd><kwd>органосохраняющее лечение</kwd><kwd>удаление лимфатического узла</kwd><kwd>магнитно-резонансная томография</kwd><kwd>ультрасонография</kwd></kwd-group><kwd-group xml:lang="en"><kwd>breast cancer</kwd><kwd>sentinel lymph node</kwd><kwd>biopsy</kwd><kwd>organ-preserving treatment</kwd><kwd>lymph node removal</kwd><kwd>magnetic resonance imaging</kwd><kwd>ultrasonography</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Каприн А.Д., Старинский В.В., Шахзадова А.О. (ред.) Злокачественные новообразования в России в 2020 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена — филиал ФГБУ «НМИЦ радиологии» Минздрава России; 2021.</mixed-citation><mixed-citation xml:lang="en">Kaprin A.D., Starinsky V.V., Shakhzadova A.O. (eds.) Malignant neoplasms in Russia in 2020 (morbidity and mortality). P.A Gertsen Moscow Research Oncology Institute — branch of the National Medical Research Center for Radiology; 2021 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Lin A.P., Huang T.W., Tam K.W. Treatment of male breast cancer: meta-analysis of real-world evidence. Br J Surg. 2021;108(9):1034–42. DOI: 10.1093/bjs/znab279</mixed-citation><mixed-citation xml:lang="en">Lin A.P., Huang T.W., Tam K.W. Treatment of male breast cancer: meta-analysis of real-world evidence. Br J Surg. 2021;108(9):1034–42. DOI: 10.1093/bjs/znab279</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Giuliano A.E., Ballman K.V., McCall L., Beitsch P.D., Brennan M.B., Kelemen P.R., et al. Effect of axillary dissection vs no axillary dissection on 10-year overall sur vival among women with invasive breast cancer and sentinel node metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA 2017;318(10):918–26. DOI: 10.1001/jama.2017.11470</mixed-citation><mixed-citation xml:lang="en">Giuliano A.E., Ballman K.V., McCall L., Beitsch P.D., Brennan M.B., Kelemen P.R., et al. Eff ect of axillary dissection vs no axillary dissection on 10-year overall sur vival among women with invasive breast cancer and sentinel node metastasis: Th e ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA 2017;318(10):918–26. DOI: 10.1001/jama.2017.11470</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Heiranizadeh N., Rafiei Shahamabadi M., Dehghan H.R., JafariNedooshan J., Kargar S., Zare M., et al. Comparing early-stage breast cancer patients with sentinel lymph node metastasis with and without completion axillary lymph node dissection: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2022;23(8):2561–71. DOI: 10.31557/APJCP.2022.23.8.2561</mixed-citation><mixed-citation xml:lang="en">Heiranizadeh N., Rafi ei Shahamabadi M., Dehghan H.R., Jafari- Nedooshan J., Kargar S., Zare M., et al. Comparing early-stage breast cancer patients with sentinel lymph node metastasis with and without completion axillary lymph node dissection: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2022;23(8):2561–71. DOI: 10.31557/APJCP.2022.23.8.2561</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Mathias B.J., Sun J., Sun W., Zhou J.M., Fulp W.J., Laronga C., et al. Surgeon bias in the management of positive sentinel lymph nodes. Clin Breast Cancer. 2021;21(1):74–9. DOI: 10.1016/j.clbc.2020.07.010</mixed-citation><mixed-citation xml:lang="en">Mathias B.J., Sun J., Sun W., Zhou J.M., Fulp W.J., Laronga C., et al. Surgeon bias in the management of positive sentinel lymph nodes. Clin Breast Cancer. 2021;21(1):74–9. DOI: 10.1016/j.clbc.2020.07.010</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Семиглазов В.Ф., Криворотько П.В., Жильцова Е.К., Канаев С.В., Труфанова Е.С., Крживицкий П.И. и др. Двадцатилетний опыт изучения биопсии сигнальных лимфатических узлов при раке молочной железы. Опухоли женской репродуктивной системы. 2020;16(1):12–20. DOI: 10.17650/1994-4098-2020-16-1-12-20</mixed-citation><mixed-citation xml:lang="en">Semiglazov V.F., Krivorotko P.V., Zhiltsova E.K., Kanaev S.V., Trufanova E.S., Krzhivitskiy P.I., et al. Twenty-year experience of examining biopsies of signal lymph nodes in breast cancer. Tumors of female reproductive system. 2020;16(1):12–20 (In Russ.) DOI: 10.17650/1994-4098-2020-16-1-12-20</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ганусевич О.Н., Нестерович Т.Н., Федоркевич И.В. Современные подходы к лечению рака молочной железы (по материалам конференции в Сан-Галлен, 2017). Проблемы здоровья и экологии. 2018;3:12–8. DOI: 10.51523/2708-6011.2018-15-3-3</mixed-citation><mixed-citation xml:lang="en">Ganusevich O.N., Nesterovich T.N., Fedorkevich I.V. Modern approaches to breast cancer treatment (by the proceedings of St. Gallen International Breast Cancer Conference, 2017). Health and Ecology Issues. 2018;3:11–8 (In Russ.). DOI: 10.51523/2708-6011.2018-15-3-3</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Magnoni F., Galimberti V., Corso G., Intra M., Sacchini V., Veronesi P. Axillary surgery in breast cancer: An updated historical perspective. Semin Oncol. 2020;47(6):341–52. DOI: 10.1053/j.seminoncol.2020.09.001</mixed-citation><mixed-citation xml:lang="en">Magnoni F., Galimberti V., Corso G., Intra M., Sacchini V., Veronesi P. Axillary surgery in breast cancer: An updated historical perspective. Semin Oncol. 2020;47(6):341–52. DOI: 10.1053/j.seminoncol.2020.09.001</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Исмагилов А.Х., Аснина Н.Г., Азаров Г.А. Биопсия сигнальных лимфатических узлов: история и современность. Опухоли женской репродуктивной системы. 2018;14(1):38–46. DOI: 10.17650/1994-4098-2018-14-1-38-46</mixed-citation><mixed-citation xml:lang="en">Ismagilov A.K., Asnina N.G., Azarov G.A. Sentinel lymph node biopsy: history and current concepts. Tumors of female reproductive system. 2018;14(1):38–46 (In Russ.). DOI: 10.17650/1994-4098-2018-14-1-38-46</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Клинические рекомендации: Рак молочной железы. Министерство здравоохранения Российской Федерации. Кодирование по Международной статистической классификации болезней и проблем, связанных со здоровьем: D05, C50. Год утверждения (частота пересмотра): 2021. Возрастная категория: Взрослые. URL: https://cr.minzdrav.gov.ru/schema/379_4</mixed-citation><mixed-citation xml:lang="en">Clinical guidelines: breast cancer. Ministry of Health of Russian Federation. Coding according the International Statistical Classifi cation of Diseases and Related Health Problems: D05, C50. Approval year (revision frequency): 2021. Age group: adults. URL: https://cr.minzdrav.gov.ru/schema/379_4</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Винокурова М.А. Независимая оценка качества условий оказания услуг медицинскими организациями: административно-правовые основы регулирования, сущность и значение. Социально-политические науки. 2019;4:125–9.</mixed-citation><mixed-citation xml:lang="en">Vinokurova M.A. Independent quality assessment of the service conditions of medical institutions: the administrative regulation, essence and importance. Sociopolitical Sciences. 2019;4:125–9 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Кондратова Н.В. Методические подходы к исследованию удовлетворенности пациентов в медицинской организации. В мире научных открытий. 2016;5(77):23–36. DOI: 10.12731/wsd-2016-5-2</mixed-citation><mixed-citation xml:lang="en">Kondratova N.V. Methodological approaches for patient satisfaction survey in medical organization. Siberian Journal of Life Sciences and Agriculture. 2016;5(77):23–36 (In Russ.). DOI: 10.12731/wsd-2016-5-2</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kwon B.R., Chang J.M., Lee J., Shin S.U., Lee S.H., Cho N., et al. Detection of axillary lymph node recurrence in patients with personal history of breast cancer treated with sentinel lymph node biopsy (SLNB): results of postoperative combined ultrasound and mammography screening over five consecutive years. Acta Radiol. 2019;60(7):852–8. DOI: 10.1177/0284185118805264</mixed-citation><mixed-citation xml:lang="en">Kwon B.R., Chang J.M., Lee J., Shin S.U., Lee S.H., Cho N., et al. Detection of axillary lymph node recurrence in patients with personal history of breast cancer treated with sentinel lymph node biopsy (SLNB): results of postoperative combined ultrasound and mammography screening over five consecutive years. Acta Radiol. 2019;60(7):852–8. DOI: 10.1177/0284185118805264</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Lai H.W., Chang Y.L., Chen S.T., Chang Y.J., Wu W.P., Chen D.R., et al. Revisit the practice of lymph node biopsy in patients diagnosed as ductal carcinoma in situ before operation: a retrospective analysis of 682 cases and evaluation of the role of breast MRI. World J Surg Oncol. 2021;19(1):263. DOI: 10.1186/s12957-021-02336-w</mixed-citation><mixed-citation xml:lang="en">Lai H.W., Chang Y.L., Chen S.T., Chang Y.J., Wu W.P., Chen D.R., et al. Revisit the practice of lymph node biopsy in patients diagnosed as ductal carcinoma in situ before operation: a retrospective analysis of 682 cases and evaluation of the role of breast MRI. World J Surg Oncol. 2021;19(1):263. DOI: 10.1186/s12957-021-02336-w</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Huang X., Shi Z., Mai J., Liu C., Liu C., Chen S., et al. An MRI-based scoring system for preoperative prediction of axillary response to neoadjuvant chemotherapy in node-positive breast cancer: a multicenter retrospective study. Acad Radiol. 2022;S1076-6332(22)00513-X. DOI: 10.1016/j.acra.2022.09.022</mixed-citation><mixed-citation xml:lang="en">Huang X., Shi Z., Mai J., Liu C., Liu C., Chen S., et al. An MRI-based scoring system for preoperative prediction of axillary response to neoadjuvant chemotherapy in node-positive breast cancer: a multicenter retrospective study. Acad Radiol. 2022;S1076-6332(22)00513-X. DOI: 10.1016/j.acra.2022.09.022</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Di Paola V., Mazzotta G., Pignatelli V., Bufi E., D’Angelo A., Conti M., et al. Staging in breast cancer: importance of MRI and ultrasoundbased imaging. Cancers (Basel). 2022;14(17):4270. DOI: 10.3390/cancers14174270</mixed-citation><mixed-citation xml:lang="en">Di Paola V., Mazzotta G., Pignatelli V., Bufi E., D’Angelo A., Conti M., et al. Staging in breast cancer: importance of MRI and ultrasoundbased imaging. Cancers (Basel). 2022;14(17):4270. DOI: 10.3390/cancers14174270</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Arisio R., Borella F., Porpiglia M., Durando A., Bellino R., Bau M.G., et al. Axillary dissection vs. no axillary dissection in breast cancer patients with positive sentinel lymph node: a single institution experience. In Vivo. 2019;33(6):1941–7. DOI: 10.21873/invivo.11689</mixed-citation><mixed-citation xml:lang="en">Arisio R., Borella F., Porpiglia M., Durando A., Bellino R., Bau M.G., et al. Axillary dissection vs. no axillary dissection in breast cancer patients with positive sentinel lymph node: a single institution experience. In Vivo. 2019;33(6):1941–7. DOI: 10.21873/invivo.11689</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Zheng Q., Luo H., Xia W., Lu Q., Jiang K., Hong R., et al. Long-term survival after sentinel lymph node biopsy or axillary lymph node dissection in pN0 breast cancer patients: a population-based study. Breast Cancer Res Treat. 2022 Oct 7. DOI: 10.1007/s10549-022-06746-6</mixed-citation><mixed-citation xml:lang="en">Zheng Q., Luo H., Xia W., Lu Q., Jiang K., Hong R., et al. Long-term survival aft er sentinel lymph node biopsy or axillary lymph node dissection in pN0 breast cancer patients: a population-based study. Breast Cancer Res Treat. 2022 Oct 7. DOI: 10.1007/s10549-022-06746-6</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Knape N., Park J.H., Agala C.B., Spanheimer P., Morrow M., DownsCanner S., et al. Can we forgo sentinel lymph node biopsy in women aged ≥ 50 years with early-stage hormone-receptor-positive HER2-negative special histologic subtype breast cancer? Ann Surg Oncol. 2022 Oct 10. DOI: 10.1245/s10434-022-12626-6</mixed-citation><mixed-citation xml:lang="en">Knape N., Park J.H., Agala C.B., Spanheimer P., Morrow M., Downs- Canner S., et al. Can we forgo sentinel lymph node biopsy in women aged ≥ 50 years with early-stage hormone-receptor-positive HER2- negative special histologic subtype breast cancer? Ann Surg Oncol. 2022 Oct 10. DOI: 10.1245/s10434-022-12626-6</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Huo Y., Fan T., Chen S., Liu Q., Fang Y., Yao F. Thematic trends and knowledge structure map of sentinel lymph node biopsy for breast cancer: a bibliometric analysis from 2010 to 2019. Transl Cancer Res. 2022;11(9):3092–107. DOI: 10.21037/tcr-21-2841</mixed-citation><mixed-citation xml:lang="en">Huo Y., Fan T., Chen S., Liu Q., Fang Y., Yao F. Thematic trends and knowledge structure map of sentinel lymph node biopsy for breast cancer: a bibliometric analysis from 2010 to 2019. Transl Cancer Res. 2022;11(9):3092–107. DOI: 10.21037/tcr-21-2841</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">van Bekkum S., Kraima A.C., Westenend P.J., Plaisier P.W., MenkePluijmers M.B.E. The dilemma after an unforeseen positive sentinel node in primary breast cancer: is completion axillary dissection necessary? World J Surg. 2020;44(11):3801–9. DOI: 10.1007/s00268-020-05650-8</mixed-citation><mixed-citation xml:lang="en">van Bekkum S., Kraima A.C., Westenend P.J., Plaisier P.W., Menke- Pluijmers M.B.E. Th e dilemma aft er an unforeseen positive sentinel node in primary breast cancer: is completion axillary dissection necessary? World J Surg. 2020;44(11):3801–9. DOI: 10.1007/s00268-020-05650-8</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
